• Je něco špatně v tomto záznamu ?

Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer ́s disease patients

D. Ehrlich, A. Dunzinger, G. Malsiner-Walli, B. Grün, R. Topakian, M. Hodolic, E. Kainz, R. Pichler

. 2021 ; 56 (1) : 23-31. [pub] 20211222

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011658

BACKGROUND: Beta amyloid (Aβ) causes synaptic dysfunction leading to neuronal death. It is still controversial if the magnitude of Aβ deposition correlates with the degree of cognitive impairment. Diagnostic imaging may lead to a better understanding the role of Aβ in development of cognitive deficits. The aim of the present study was to investigate if Aβ deposition in the corresponding brain region of early stage Alzheimer ́s disease (AD) patients, directly correlates to neuronal dysfunction and cognitive impairment indicated by reduced glucose metabolism. PATIENTS AND METHODS: In 30 patients with a clinical phenotype of AD and amyloid positive brain imaging, 2-[18F] fluoro-2-deoxy-d-glucose (FDG) PET/CT was performed. We extracted the average [18F] flutemetamol (Vizamyl) uptake for each of the 16 regions of interest in both hemispheres and computed the standardized uptake value ratio (SUVR) by dividing the Vimazyl intensities by the mean signal of positive and negative control regions. Data were analysed using the R environment for statistical computing and graphics. RESULTS: Any negative correlation between Aβ deposition and glucose metabolism in 32 dementia related and corresponding brain regions in AD patients was not found. None of the correlation coefficient values were statistically significant different from zero based on two-sided p- value. CONCLUSIONS: Regional Aβ deposition did not correlate negatively with local glucose metabolism in early stage AD patients. Our findings support the role of Aβ as a valid biomarker, but does not permit to conclude that Aβ is a direct cause for an aberrant brain glucose metabolism and neuronal dysfunction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011658
003      
CZ-PrNML
005      
20220506130159.0
007      
ta
008      
220425s2021 pl f 000 0|eng||
009      
AR
024    7_
$a 10.2478/raon-2021-0051 $2 doi
035    __
$a (PubMed)34957735
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Ehrlich, Daniela $u Department of Gerontology, Kepler University Hospital, Neuromed Campus, Linz, Austria
245    10
$a Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer ́s disease patients / $c D. Ehrlich, A. Dunzinger, G. Malsiner-Walli, B. Grün, R. Topakian, M. Hodolic, E. Kainz, R. Pichler
520    9_
$a BACKGROUND: Beta amyloid (Aβ) causes synaptic dysfunction leading to neuronal death. It is still controversial if the magnitude of Aβ deposition correlates with the degree of cognitive impairment. Diagnostic imaging may lead to a better understanding the role of Aβ in development of cognitive deficits. The aim of the present study was to investigate if Aβ deposition in the corresponding brain region of early stage Alzheimer ́s disease (AD) patients, directly correlates to neuronal dysfunction and cognitive impairment indicated by reduced glucose metabolism. PATIENTS AND METHODS: In 30 patients with a clinical phenotype of AD and amyloid positive brain imaging, 2-[18F] fluoro-2-deoxy-d-glucose (FDG) PET/CT was performed. We extracted the average [18F] flutemetamol (Vizamyl) uptake for each of the 16 regions of interest in both hemispheres and computed the standardized uptake value ratio (SUVR) by dividing the Vimazyl intensities by the mean signal of positive and negative control regions. Data were analysed using the R environment for statistical computing and graphics. RESULTS: Any negative correlation between Aβ deposition and glucose metabolism in 32 dementia related and corresponding brain regions in AD patients was not found. None of the correlation coefficient values were statistically significant different from zero based on two-sided p- value. CONCLUSIONS: Regional Aβ deposition did not correlate negatively with local glucose metabolism in early stage AD patients. Our findings support the role of Aβ as a valid biomarker, but does not permit to conclude that Aβ is a direct cause for an aberrant brain glucose metabolism and neuronal dysfunction.
650    12
$a Alzheimerova nemoc $x diagnostické zobrazování $x metabolismus $7 D000544
650    _2
$a amyloidní beta-protein $x metabolismus $7 D016229
650    _2
$a fluorodeoxyglukosa F18 $7 D019788
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a lidé $7 D006801
650    _2
$a PET/CT $7 D000072078
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dunzinger, Andreas $u Institute of Nuclear Medicine, Kepler University Hospital, Neuromed Campus, Linz, Austria
700    1_
$a Malsiner-Walli, Gertraud $u Institute for Applied Statistics, Johannes Kepler University, Linz, Austria
700    1_
$a Grün, Bettina $u Institute for Statistics and Mathematics, WU University of Economics and Business, Vienna, Austria
700    1_
$a Topakian, Raffi $u Department of Neurology, Klinikum Wels-Grieskirchen, Wels, Austria
700    1_
$a Hodolic, Marina $u Nuclear Medicine Research Department, IASON, Graz, Austria $u Department of Nuclear Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Kainz, Elmar $u Department of Gerontology, Kepler University Hospital, Neuromed Campus, Linz, Austria
700    1_
$a Pichler, Robert $u Institute of Nuclear Medicine, Kepler University Hospital, Neuromed Campus, Linz, Austria $u Institute of Nuclear Medicine, Steyr Hospital, Steyr, Austria $u Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria
773    0_
$w MED00004048 $t Radiology and oncology $x 1581-3207 $g Roč. 56, č. 1 (2021), s. 23-31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34957735 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130151 $b ABA008
999    __
$a ok $b bmc $g 1789324 $s 1162856
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 56 $c 1 $d 23-31 $e 20211222 $i 1581-3207 $m Radiology and oncology $n Radiol. oncol. (Tik. izd.) $x MED00004048
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace